• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗一家转诊医院的一名新冠肺炎患者:一个典型病例。

A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.

作者信息

Ghiasvand Fereshteh, Miandoab Sepideh Zahak, Harandi Hamid, Golestan Fereshteh Shahmari, Alinaghi Seyed Ahmad Seyed

机构信息

Liver Transplantation Research Center, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Infect Disord Drug Targets. 2020;20(4):559-562. doi: 10.2174/1871526520666200429115535.

DOI:10.2174/1871526520666200429115535
PMID:32348232
Abstract

After the initial outbreak of the new Coronavirus in Wuhan at the end of December 2019, many new cases were reported in other provinces of China and also many other countries over the world, including South Korea, Italy, Iran, Japan, and 68 other countries. We present a case report of a 61-year-old woman with a history of diabetes mellitus who was referred to the emergency department of a referral hospital in Tehran, Iran. The patient presented with fever, chills, and myalgia within three days. Laboratory analysis showed increased levels of erythrocyte sedimentation rate (ESR), and mild leukopenia. SARS-CoV-2 PCR test -under the Iran Ministry of Health and Medical Education (MoH&ME) guidelines- was conducted and the result was positive. The chest X-ray showed bilateral ground-glass opacity. O2 saturation was 87% (without O2 therapy). The patient was hospitalized and treated with Oseltamivir 75 mg every 12 hours, Lopinavir/Ritonavir (Kaletra) 400/100 mg every 12 hours and hydroxychloroquine 400 mg stat. The patient's last O2 saturation measured was 93% and she had no fever on the 10th day of hospitalization. Therefore, she was discharged from hospital and quarantined at home according to the Iran Ministry of Health protocol.

摘要

2019年12月底新型冠状病毒在武汉首次爆发后,中国其他省份以及世界上许多其他国家都报告了许多新病例,包括韩国、意大利、伊朗、日本以及其他68个国家。我们报告一例61岁患有糖尿病史的女性病例,该患者被转诊至伊朗德黑兰一家转诊医院的急诊科。患者在三天内出现发热、寒战和肌痛。实验室分析显示红细胞沉降率(ESR)升高,轻度白细胞减少。按照伊朗卫生和医学教育部(MoH&ME)的指导方针进行了SARS-CoV-2 PCR检测,结果呈阳性。胸部X线显示双侧磨玻璃影。氧饱和度为87%(未进行氧疗)。患者住院治疗,每12小时服用75毫克奥司他韦,每12小时服用400/100毫克洛匹那韦/利托那韦(克力芝),单次服用400毫克羟氯喹。患者最后一次测得氧饱和度为93%,住院第10天无发热。因此,她已出院,并按照伊朗卫生部的方案在家中隔离。

相似文献

1
A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.伊朗一家转诊医院的一名新冠肺炎患者:一个典型病例。
Infect Disord Drug Targets. 2020;20(4):559-562. doi: 10.2174/1871526520666200429115535.
2
The COVID-19 Outbreak in Iran; The First Patient with a Definite Diagnosis.伊朗的 COVID-19 疫情爆发;首例明确诊断的患者。
Arch Iran Med. 2020 Jul 1;23(7):503-504. doi: 10.34172/aim.2020.48.
3
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.中国武汉以外地区多次 PCR 检测结果为阴性的 COVID-19 患者:一例病例报告。
BMC Infect Dis. 2020 Jul 16;20(1):517. doi: 10.1186/s12879-020-05245-7.
4
Clinical features and treatment of COVID-19 patients in northeast Chongqing.重庆东北部地区 COVID-19 患者的临床特征和治疗方法。
J Med Virol. 2020 Jul;92(7):797-806. doi: 10.1002/jmv.25783. Epub 2020 Apr 1.
5
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
6
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.韩国大邱市 98 例住院 SARS-CoV-2 感染患者的临床特征和结局:一项简要描述性研究。
Yonsei Med J. 2020 May;61(5):431-437. doi: 10.3349/ymj.2020.61.5.431.
7
[Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department].[儿科急诊科中严重急性呼吸综合征冠状病毒2型聚合酶链反应阳性病例的评估]
Mikrobiyol Bul. 2020 Oct;54(4):629-637. doi: 10.5578/mb.70086.
8
A Case of COVID 19 and Coinfection.COVID-19 合并感染病例报告
Arch Iran Med. 2020 Aug 1;23(8):568-569. doi: 10.34172/aim.2020.62.
9
Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience.新型冠状病毒病 2019(COVID-19)在心脏移植人群中的表现:单中心经验。
Eur J Cardiothorac Surg. 2020 Nov 1;58(5):899-906. doi: 10.1093/ejcts/ezaa323.
10
Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran.2019 年冠状病毒病与甲型流感的合并感染:来自伊朗的报告。
Arch Iran Med. 2020 Apr 1;23(4):239-243. doi: 10.34172/aim.2020.04.

引用本文的文献

1
The comparison of clinical, laboratory, and radiological findings in immunocompromised and immunocompetent patients with COVID-19: A case-control study.免疫抑制和免疫功能正常的 COVID-19 患者的临床、实验室和影像学表现比较:一项病例对照研究。
Immun Inflamm Dis. 2023 Apr;11(4):e806. doi: 10.1002/iid3.806.
2
The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review.高压氧疗法(HBOT)对 2019 年冠状病毒病(COVID-19)的影响:系统评价。
Eur J Med Res. 2021 Aug 19;26(1):96. doi: 10.1186/s40001-021-00570-2.
3
Genetic susceptibility of COVID-19: a systematic review of current evidence.
COVID-19 的遗传易感性:当前证据的系统评价。
Eur J Med Res. 2021 May 20;26(1):46. doi: 10.1186/s40001-021-00516-8.
4
Late Complications of COVID-19; a Systematic Review of Current Evidence.2019冠状病毒病的晚期并发症;当前证据的系统评价
Arch Acad Emerg Med. 2021 Jan 20;9(1):e14. doi: 10.22037/aaem.v9i1.1058. eCollection 2021.
5
Reinfection risk of novel coronavirus (COVID-19): A systematic ‎review of current evidence.新型冠状病毒(COVID-19)的再感染风险:当前证据的系统评价
World J Virol. 2020 Dec 15;9(5):79-90. doi: 10.5501/wjv.v9.i5.79.
6
A systematic review of ECG findings in patients with COVID-19.一项关于 COVID-19 患者心电图表现的系统评价。
Indian Heart J. 2020 Nov-Dec;72(6):500-507. doi: 10.1016/j.ihj.2020.11.007. Epub 2020 Nov 13.
7
Recent progress of antiviral therapy for coronavirus disease 2019.新型冠状病毒病抗病毒治疗的最新进展。
Eur J Pharmacol. 2021 Jan 5;890:173646. doi: 10.1016/j.ejphar.2020.173646. Epub 2020 Oct 24.
8
Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence.因冠状病毒病(COVID-19)引起的嗅觉和味觉障碍:当前证据综述。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):307-312. doi: 10.1007/s00405-020-06120-6. Epub 2020 Jun 17.